Structural insights into the human RyR2 N-terminal region involved in cardiac arrhythmias

Lubomír Borko1, Vladena Bauerová-Hlinková1, Eva Hostinová1

  • 1Department of Biochemistry and Structural Biology, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská cesta 21, 845 51 Bratislava, Slovakia.

Insights

The human ryanodine receptor 2 (hRyR2) N-terminus structure reveals key interactions stabilizing the protein. This finding explains arrhythmogenic mutations and identifies binding sites for regulatory proteins.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biophysics
  • Structural Biology

Background:

  • The N-terminal region of human ryanodine receptor 2 (hRyR2) is crucial for cardiomyocyte contraction and is implicated in over 30 arrhythmogenic mutations.
  • This region also serves as a binding site for phosphoprotein phosphatase 1, a key regulator of cardiac function.

Purpose of the Study:

  • To determine the solution and crystal structures of the hRyR2 N-terminal region under near-physiological conditions.
  • To elucidate the structural basis for arrhythmogenic mutations and identify regulatory interaction sites.

Main Methods:

  • X-ray crystallography and solution structure determination of the hRyR2 N-terminal region (amino acids 1-606).
  • Homology modeling and docking into cryo-electron microscopy maps of RyR1.
  • Analysis of mutation stability based on residue interactions.

Main Results:

  • The hRyR2 N-terminus adopts a globular structure stabilized by interactions among domains A, B, and C, with a central helix playing a key role.
  • An anion-binding site present in mouse RyR2 is absent in the human ortholog.
  • Arrhythmogenic mutations in the central helix show differential stability linked to altered residue contacts.
  • Channel gating involves significant C(α) atom movements in the N-terminal domains.

Conclusions:

  • The determined structure provides insights into the stability of the hRyR2 N-terminus and the mechanism of arrhythmogenic mutations.
  • The findings predict the location of functional sites, including those for spinophilin and phosphoprotein phosphatase 1, on the RyR channel surface.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.7K
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
11.3K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
11.1K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.2K